For Matthew Spicer, August 2023 should have been one of the most exciting times of his life. Instead, he received a ...
Tumor-infiltrating B cells may reveal naturally selected antibodies and new immunotherapy targets, offering a potential path ...
Gilead pauses KITE-753 trials over ICANS; Agios' mitapivat PDUFA delayed; Acumen scraps sabirnetug; BMS drops BMS-986495; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results